Holen Sie sich die Stockscreener-App
1.08
1.89%
0.02
Handel nachbörslich:
1.02
-0.06
-5.56%
Schlusskurs vom Vortag:
$1.06
Offen:
$1.07
24-Stunden-Volumen:
64,305
Relative Volume:
0.49
Marktkapitalisierung:
$45.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.38M
KGV:
-2.7692
EPS:
-0.39
Netto-Cashflow:
$-25.19M
1W Leistung:
+13.41%
1M Leistung:
+31.82%
6M Leistung:
-10.74%
1J Leistung:
-21.74%
1-Tages-Spanne:
$1.02
$1.09
1-Wochen-Bereich:
$0.93
$1.09
52-Wochen-Spanne:
$0.51
$1.60
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile
Firmenname
Connect Biopharma Holdings Ltd Adr
Sektor
Branche
Telefon
858-727-1040
Adresse
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Vergleichen Sie CNTB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd Adr
|
1.08 | 45.50M | 0 | -21.38M | -25.19M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-13 | Eingeleitet | Jefferies | Buy |
| 2021-04-13 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-13 | Eingeleitet | SVB Leerink | Outperform |
Connect Biopharma Holdings Ltd Adr Aktie (CNTB) Neueste Nachrichten
Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewswire Inc.
Connect Biopharma begins Phase 2 asthma study - Investing.com
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa
Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com
FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com
Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com
Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India
Connect Biopharma faces Nasdaq delisting over share price - Investing.com
Connect Biopharma stock hits 52-week low at $0.76 - Investing.com
Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
Top 3 Aerospace and Defense Stocks Flying Under the Radar - The Globe and Mail
CPIX Stock Quote Price and Forecast - CNN
Stocks Set to Open Lower as Investors Await Fed Meeting, Banking Sector Remains in Focus - Barchart.com
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - USC-China Institute
ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire
Connect Biopharma Holdings Limited: Shareholders Board Members Managers and Company Profile | US2075231017 - Marketscreener.com
Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat
Finanzdaten der Connect Biopharma Holdings Ltd Adr-Aktie (CNTB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):